Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents
US8333974B2 · kind B2 · utility
0Cited by
64References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 2007 |
| Grant date | Dec 18, 2012 |
| Priority date | — |
| Expiry date | Feb 20, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides effective dosing regimes for neural stem cell proliferating agents, kits containing effective dosing regimes for neural stem cell proliferating agents, and uses thereof. In particular, neural stem cell proliferating agents, such as hCG, prolactin and EPO are delivered to mammalian subjects at low doses in a continuous fashion over several days, as opposed to delivery of high doses in a short period of time.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.